Better Buy: Moderna vs. Biocryst Pharmaceuticals
Most stocks have performed dismally so far in 2020 due to the COVID-19 outbreak. But biotech stocks, in general, have fared pretty well. Some have even delivered exceptional returns in recent months.
Moderna (NASDAQ: MRNA) is definitely in that category, with its shares skyrocketing 160% higher. Biocryst Pharmaceuticals (NASDAQ: BCRX) is an example of a biotech stock that hasn't been a huge winner but still outperformed major market indexes. Its shares are down slightly year to date -- much better than the double-digit percentage decline for the S&P 500 index.
Which of these two biotech stocks is the better pick for investors going forward? Here's how Moderna and Biocryst compare.
Source Fool.com
